Type : Contract
ILLUMINA NEXTSEQ REAGENT KITS Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Thu Dec 22 18:00:00 GMT 2022
ILLUMINA NEXTSEQ REAGENT KITS Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Thu Dec 22 18:00:00 GMT 2022
ILLUMINA INC:1107104 [21-002130] - THE GENOME ANALYZER CORE FACILITY WITHIN NIAMS REQUESTS THE PURCHASE OF SEQUENCING REAGENT KITS FOR OUR ILLUMINA NOVASEQ 6000 AND NEXTSEQ 550. THESE KITS ARE EXTREME... Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Tue Sep 02 17:00:00 GMT 2025
Ready-to-use cartridges redefine ease-of-use.Below are the items needed for this action:Catalog # Description Quantity 200224908 NextSeq 500/550 High Output Kit 1The proposed vendor, Illumina Incorporated, is the sole manufacturer of these reagent kits.
ILLUMINA REAGENTS NEXTSEQ 500/550 HIGH OUTPUT KITS AND NEXTERA DNA CD INDEXES AND FLEX LIBRARY PREPS Solicitation ID/Procurement Identifier: HHSN268201500004I Ultimate Completion Date: Thu Jul 23 17:00:00 GMT 2020
The need is for Control Software upgrades (20038658) and Preventative Maintenance Service (SP-103-1004) on two MiSeq’s, Control Software upgrade (20038659) on one NextSeq, and a service contract on one iSeq (20023959). MiSeq, NextSeq, and iSeq are manufactured by Illumina, Inc. Additionally, MiSeq reagents kits (MS-102-3003, qty 30, delivered at two time points, 2 months apart, and FC-131-1096, qty 1) are required.
The need is for Control Software upgrades (20038658) and Preventative Maintenance Service (SP-103-1004) on two MiSeq’s, Control Software upgrade (20038659) on one NextSeq, and a service contract on one iSeq (20023959). MiSeq, NextSeq, and iSeq are manufactured by Illumina, Inc. Additionally, MiSeq reagents kits (MS-102-3003, qty 30, delivered at two time points, 2 months apart, and FC-131-1096, qty 1) are required.
sequencing kits and reagents.5-year Contract for reagents used for genetic sequencing of genetic material for microorganism serotype and variant surveillance as well as newborn screening.